- Home
- IMCR vs LTC Comparison
IMCR vs LTC Comparison
Compare IMCR & LTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- LTC
- Stock Information
- Founded
- IMCR 2008
- LTC 1992
- Country
- IMCR United Kingdom
- LTC United States
- Employees
- IMCR N/A
- LTC N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- LTC Real Estate Investment Trusts
- Sector
- IMCR Health Care
- LTC Real Estate
- Exchange
- IMCR Nasdaq
- LTC Nasdaq
- Market Cap
- IMCR 1.5B
- LTC 1.7B
- IPO Year
- IMCR 2021
- LTC 1992
- Fundamental
- Price
- IMCR $36.60
- LTC $35.37
- Analyst Decision
- IMCR Buy
- LTC Hold
- Analyst Count
- IMCR 10
- LTC 5
- Target Price
- IMCR $58.13
- LTC $37.80
- AVG Volume (30 Days)
- IMCR 440.3K
- LTC 344.6K
- Earning Date
- IMCR 05-07-2025
- LTC 05-05-2025
- Dividend Yield
- IMCR N/A
- LTC 6.44%
- EPS Growth
- IMCR N/A
- LTC 0.36
- EPS
- IMCR N/A
- LTC 1.93
- Revenue
- IMCR $333,581,000.00
- LTC $202,686,000.00
- Revenue This Year
- IMCR $25.96
- LTC N/A
- Revenue Next Year
- IMCR $8.06
- LTC $4.41
- P/E Ratio
- IMCR N/A
- LTC $18.33
- Revenue Growth
- IMCR 25.75
- LTC 3.98
- 52 Week Low
- IMCR $23.15
- LTC $31.70
- 52 Week High
- IMCR $49.05
- LTC $39.89
- Technical
- Relative Strength Index (RSI)
- IMCR 71.46
- LTC 49.40
- Support Level
- IMCR $31.14
- LTC $34.97
- Resistance Level
- IMCR $33.30
- LTC $35.86
- Average True Range (ATR)
- IMCR 1.94
- LTC 0.56
- MACD
- IMCR 0.57
- LTC -0.05
- Stochastic Oscillator
- IMCR 96.12
- LTC 37.58
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.